Jacob Hunter has been appointed as Chief Business Officer at #ALZpath ! With 15+ years of biotech & diagnostic business development experience, Jake's expertise will propel us forward in developing innovative Alzheimer's diagnostic solutions! #Leadership

Today📢 ALZpath received Alzheimer's Drug Discovery Foundation funding, backed by Bill Gates, Jeff Bezos and Leonard Lauder, to expand availability and clinical development of ALZPathDx, our highly sensitive blood assay to detect #AlzheimersDisease , even at early stages. alzpath.bio/addf-press-rel…

#ALZpath #Announces #New #Funding from the #Alzheimer 's #Drug #Discovery #Foundation ( #ADDF ) to #Advance a #Novel , #Diagnostic #Blood -Based #Assay rb.gy/sz2j1 ALZpath

📣 Exciting Presentations Utilizing Our ALZpath pTau217 Assay at #AAIC23 !

🌍 Join us in Amsterdam!

👏 Prominent researchers evaluating biomarkers for Alzheimer’s Disease that have utilized our cutting-edge pTau217 assay will present their important findings

June is Alzheimer’s & Brain Awareness Month. 💜 RETWEET to raise awareness in honor of all those impacted by Alzheimer’s and other dementia. Together, we will #ENDALZ .

At the Alzheimer's Association, diversity, equity and inclusion are vital to our mission. This month, we’re celebrating Alzheimer’s & Brain Awareness Month and #PrideMonth . 🌈🏳️‍⚧️ Thank you to all of our LGBTQ+ champions in the fight to #ENDALZ !

June is Alzheimer’s & Brain Awareness Month! #GoPurple to raise awareness in honor of the more than 6 million Americans living with Alzheimer’s. Learn more: alz.org/abam. #ENDALZ

📢A recent study evaluating our pTau217 #assay and three pTau181 assays found that the ALZpath assay provides a ‘practical diagnostic opportunity to identify #AlzheimersDisease patients’ #hubofhow #biomarkers aan.com/MSA/Public/Eve…

🎉It's launch day!! 🎉We think our new website will be a game-changer for individuals with #memory concerns, their families, busy clinicians and for ALZpath! So please head over to our website now to see it for yourself & let us know what you think💜 #Alzheimers #biomarkers

📢The new #website is launching tomorrow! 👏 Our platform was designed to provide the most advanced information, support & resources for those who have memory concerns, their families & healthcare providers. Stay tuned!🚀 #Alzheimers #biomarkers #hubofhow

Please re-Tweet if you agree: Good #caregiving focuses on what people living with #Alzheimers disease or other forms of #dementia can do (rather than what they cannot). Offer encouragement, build confidence, share love.

#happiness #kindness #quote

My wonderful mentor Liana Apostolova, MD, MSc, FAAN and some of my lab mates featured in this video. Honored to be a part of this amazing research! 🧠💜 #ENDALZ

And he's off!! 🛫 Our Chief Scientific Officer, Andreas Jeromin, PhD is on his way to #ADPD23 ! We're excited to announce that we've launched a novel, scalable and widely accessible assay for ptau 217 in blood. Stop by the AD/PD - Advances in Science & Therapy gallery to learn more! #Alzheimers #biomarkers

Are you attending this week’s Dementia Care and Caregiving Research Summit hosted by NIA Division of Behavioral and Social Research? Meet other attendees and introduce yourself on NIA's new LinkedIn account: linkedin.com/feed/update/ur… #DementiaCareSummit

Fantastic start to Day 1 of The National Institute on Aging (NIA) 2023 Dementia Care and Caregiving Research Summit! THANK YOU for including a person living with #dementia and a #carepartner in the opening session👏 Rita and Jim - thank you for sharing your stories ❤️ #ENDALZ